Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

141. Interventions effective in increasing influenza vaccination rates

Interventions effective in increasing influenza vaccination rates Interventions effective in increasing influenza vaccination rates | Cochrane Primary Care Top menu Trusted evidence. Informed decisions. Better health. Enter terms Interventions effective in increasing influenza vaccination rates Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2017 The Cochrane Collaboration | |

Cochrane PEARLS2015

142. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation

Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial (...) . Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation. Health Technology Assessment 2015; 19(16) Authors' objectives To (1) evaluate whether or not low-dose corticosteroids given as an adjunct to standard treatment is beneficial in patients who are hospitalised with severe pandemic influenza and (2) develop an 'off-the-shelf' clinical trial that is ready to be activated

Health Technology Assessment (HTA) Database.2015

143. Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic

Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} The study found that the UK Obstetric Surveillance System was useful in the investigation of pregnant women who were hospitalised with 2009 A/H1N1 influenza and for the subsequent development of a study to examine the impact and management of influenza in pregnancy, ready for activation in the event of a future pandemic. {{author}} {{($index , , , & . Marian Knight, 1 ,* Peter

NIHR HTA programme2015 Full Text: Link to full Text with Trip Pro

144. The PAndemic INfluenza Triage in the Emergency Department (PAINTED) pilot cohort study

The PAndemic INfluenza Triage in the Emergency Department (PAINTED) pilot cohort study The PAndemic INfluenza Triage in the Emergency Department (PAINTED) pilot study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit (...) 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} The study found that a standardised assessment form is acceptable to clinicians as a triage method for patients presenting to the emergency department with suspected pandemic influenza and it could be used to collect research data in an influenza pandemic. {{author}} {{($index , , , & . Steve Goodacre, ,* Andy Irving, Richard Wilson, Daniel Beever, Kirsty Challen, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield

NIHR HTA programme2015

145. Systematic review with meta analysis: Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications

Systematic review with meta analysis: Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Zanamivir for influenza in adults and children shows limited benefit for treatment of symptomatic influenza and no effect on relevant complications Article Text Therapeutics

Evidence-Based Medicine (Requires free registration)2015

146. Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective

Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective Ting E, Ungar WJ Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation Ting E, Ungar WJ. Systematic review of the cost-effectiveness of influenza immunization programs: a Canadian perspective. Toronto, ON: Technology Assessment at SickKids (TASK). 2015 Authors' conclusions From the societal perspective and in many cases the health care system perspective as well, seasonal influenza vaccination was generally found to be a cost-effective strategy. Vaccinating all pregnant and postpartum women against seasonal influenza compared

Health Technology Assessment (HTA) Database.2015

147. Fluenz Tetra - seasonal influenza in children

Fluenz Tetra - seasonal influenza in children FLUENZTETRA SUMMARY CT13920

Haute Autorite de sante2015

148. Occurrence of cardiovascular events in patients with coronary artery disease receiving the influenza vaccine

Occurrence of cardiovascular events in patients with coronary artery disease receiving the influenza vaccine "Occurrence of cardiovascular events in patients with coronary artery d" by Dilpreet Bal < > > > > > Title Author Date of Award Summer 8-8-2015 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Saje Davis-Risen, MS, PA-C Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background: Cardiovascular disease is the leading (...) cause of death worldwide with coronary artery disease (CAD) making up a majority of those deaths. Coronary artery diseases are atherosclerotic or thrombotic in nature leading to a disparity of blood in the coronary arteries and subsequent infarction of heart muscle. Influenza has been established as a pro-inflammatory agent that has been implicated in increased death rates from cardiovascular disease. With the establishment of this causal relationship, several trials were run to assess the effect

Pacific University EBM Capstone Project2015

149. Use of neuraminidase inhibitors in influenza

Use of neuraminidase inhibitors in influenza Improving School Governance | 1 Use of neuraminidase inhibitors in influenza Image: Swine Flu virus Sculpture Luke Jerram/Wellcome Images October 2015 1 Use of Neuraminidase Inhibitors in Influenza Contents 1. Summary Background Commentary on the recent publications Pipeline of new drugs and resistance Research priorities Preparedness 3 2. Introduction Terms of reference and conduct of this review Current influenza guidelines 6 3. Studies considered (...) in this report 10 4. Strengths and limitations of the studies considered Quality of evidence Individual patient data and study level analyses Lack of completeness of data Conflicts of interest and transparency 13 5. Synthesis of evidence and implications a) Treatment for any previously healthy people with influenza that is not (currently) severe (‘treat all’ approach) b) Treatment for previously healthy people who develop severe influenza c) Commencing treatment in severely ill individuals more than 48 hours

Academy of Medical Sciences2015

151. No evidence for benefits of influenza vaccine in institutional healthcare workers

No evidence for benefits of influenza vaccine in institutional healthcare workers No evidence for benefits of influenza vaccine in institutional healthcare workers | Cochrane Primary Care Top menu Trusted evidence. Informed decisions. Better health. Enter terms No evidence for benefits of influenza vaccine in institutional healthcare workers Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2017 The Cochrane Collaboration | |

Cochrane PEARLS2014

152. The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST)

The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST) The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST). The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST). Rubin GJ, Bakhshi S, Amlôt R, Fear N, Potts HWW (...) , Michie S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Rubin GJ, Bakhshi S, Amlôt R, Fear N, Potts HWW, Michie S. The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST). Health Services and Delivery Research 2014; 2(41) Authors' objectives During

Health Technology Assessment (HTA) Database.2014

153. The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age

The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months | Position statements and practice points | The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months | Canadian Paediatric Society Protecting and promoting the health and well-being of children and youth CPS Member Login | Who We Are What We Do Get (...) Involved Education/CPD Publications Careers > Share PRACTICE POINT The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age Posted: Nov 3 2014 Reaffirmed: Jan 30 2017 The Canadian Paediatric Society gives permission to print single copies of this document from our website. For permission to reprint or reproduce multiple copies, please see our . Principal author(s) Noni E MacDonald, Jane C McDonald; Canadian Paediatric Society , Paediatr Child Health

Canadian Paediatric Society2014

154. The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST)

The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST) The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST) Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page

NIHR HTA programme2014

155. Peramivir for acute uncomplicated influenza in adults

Peramivir for acute uncomplicated influenza in adults Peramivir for acute uncomplicated influenza in adults Peramivir for acute uncomplicated influenza in adults NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. Peramivir for acute uncomplicated influenza in adults. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC (...) ). Horizon Scanning Review. 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Cyclopentanes; Guanidines; Influenza, Humans Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NIHR Horizon Scanning Centre, School of Health&Population Sciences, University of Birmingham, Public Health building, Edgbaston, Birmingham, B15 2TT. Tel: +44 121 414 7831 Email: nihrhsc@contacts.bham.ac.uk

Health Technology Assessment (HTA) Database.2014

156. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. IMPORTANCE: Human infections with avian influenza A/H7N9 have resulted in high morbidity and mortality in China. OBJECTIVE: To compare safety and immunogenicity of different doses of influenza A/Shanghai/2/13 (H7N9) vaccine mixed with or without the MF59 adjuvant. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, double-blind, phase 2 trial at 4 US (...) significant difference in day 42 hemagglutination inhibition seroconversion after mixing adjuvant with either the first or both 15 µg doses (n = 34 [35%; 95% CI, 25%-45%] vs n = 47 [47%; 95% CI, 37%-58%], respectively; P = .10). Recent receipt of seasonal influenza vaccination and older age were associated with attenuated response. No vaccine-related serious adverse events occurred. Solicited postvaccination symptoms were generally mild with more local symptoms seen in participants who received

JAMA2014 Full Text: Link to full Text with Trip Pro

157. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. IMPORTANCE: The need to respond quickly to potential influenza pandemics is important. Immunologic priming (initial presentation of an antigen to allow antibody responses on revaccination) with vaccine directed toward an older avian influenza H5 strain might lead to secondary antibody responses to a single dose of more current H5 avian influenza vaccine. OBJECTIVES: To assess priming (...) with the older avian influenza A/Vietnam/1203/2004(H5N1) (Vietnam) vaccine and to conduct dose-response studies with vaccine directed against the more contemporary H5N1 avian influenza virus, influenza A/Anhui/01/2005 (Anhui). DESIGN, SETTING, AND PARTICIPANTS: Multicenter US randomized clinical trial beginning in June 2010 with follow-up continuing through October 2011 enrolling 72 healthy adults who were vaccinated 1 year previously with the Vietnam vaccine and 565 vaccine-naive adults. INTERVENTIONS

JAMA2014 Full Text: Link to full Text with Trip Pro

158. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y

Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk (...) 18- to 64-year-olds Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds Nicholson KG, Abrams KR, Batham S, Medina MJ, Warren FC, Barer M, Bermingham A, Clark TW, Latimer N, Fraser M, Perera N, Rajakumar K, Zambon M Record Status This is a bibliographic record of a published health

Health Technology Assessment (HTA) Database.2014

159. Intranasal influenza vaccine for children (Fluenz): it is better to keep to the injectable vaccine

Intranasal influenza vaccine for children (Fluenz): it is better to keep to the injectable vaccine Prescrire IN ENGLISH - Spotlight ''Intranasal influenza vaccine for children (Fluenz°): it is better to keep to the injectable vaccine'', 1 September 2013 {1} {1} {1} | | > > > Intranasal influenza vaccine for children (Fluenz°): it is better to keep to the injectable vaccine Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |    (...) |   |   |   |   |   |  Spotlight Intranasal influenza vaccine for children (Fluenz°): it is better to keep to the injectable vaccine In children where vaccination against influenza is advisable, the live attenuated influenza intranasal vaccine has not been evaluated in terms of influenza complications. It is better to keep to the injectable vaccine. Vaccination of children against influenza is offered when there is an increased risk of complications: severe

Prescrire2014

160. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y

Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk (...) 18- to 64-year olds Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} Study finds no evidence to support routine testing with point-of-care tests for either influenza

NIHR HTA programme2014